[1]
Destiani, D.P. et al. 2017. COST-EFFECTIVENESS ANALYSIS OF CEFTAZIDIME-LEVOFLOXACIN AND CEFOTAXIME-ERYTHROMYCIN AS EMPIRICAL ANTIBIOTIC COMBINATIONS IN RESPIRATORY INFECTION-INDUCED SEPSIS. Asian Journal of Pharmaceutical and Clinical Research. 10, 14 (May 2017), 119–121. DOI:https://doi.org/10.22159/ajpcr.2017.v10s2.19515.